Unique Chemical Signature in Chronic Fatigue Syndrome Identified
This study provides the first comprehensive, quantitative demonstration of the metabolomic deficiencies in chronic fatigue syndrome.
This study provides the first comprehensive, quantitative demonstration of the metabolomic deficiencies in chronic fatigue syndrome.
In an email interview with Rheumatology Advisor, Louise Sharpe, PhD, spoke about the practical ramifications of her research for clinicians who treat rheumatoid arthritis.
Findings from study may eventually lead to expanded treatment options for binge drinking.